Body

DNA 'Trojan horse' smuggles drugs into resistant cancer cells

COLUMBUS, Ohio--Researchers at The Ohio State University are working on a new way to treat drug-resistant cancer that the ancient Greeks would approve of--only it's not a Trojan horse, but DNA that hides the invading force.

In this case, the invading force is a common cancer drug.

In laboratory tests, leukemia cells that had become resistant to the drug absorbed it and died when the drug was hidden in a capsule made of folded up DNA.

'Kurly' protein keeps cilia moving, oriented in the right direction

A new study of a protein found in cilia - the hair-like projections on the cell surface - may help explain how genetic defects in cilia play a role in developmental abnormalities, kidney disease and a number of other disorders.

Natural sugar may treat fatty liver disease

Nonalcoholic fatty liver disease, a condition closely linked to obesity, affects roughly 25 percent of people in the U.S. There is no drug treatment for the disease, although weight loss can reduce the buildup of fat in the liver.

Now, studying mice, new research shows that a natural sugar called trehalose prevents the sugar fructose -- thought to be a major contributor to nonalcoholic fatty liver disease -- from entering the liver and triggers a cellular housekeeping process that cleans up excess fat buildup inside liver cells.

Dietary link to stunted growth identified

National Institutes of Health, Intramural Research Program of the National Institute on Aging, Children's Discovery Institute of Washington University and St. Louis Children's Hospital, Hickey Family Foundation

Worldwide, an estimated 25 percent of children under age 5 suffer from stunted growth and development. The most visible characteristic is short stature, but the effects of stunting are far more profound: The condition prevents children from reaching their cognitive potential; makes them more susceptible to illness and infection; and shortens their life spans.

Fat cells outlive skinny ones

Cells with higher fat content outlive lean cells, says a new study from Michigan State University.

This study has implications for larger organisms, such as humans, as the results support the phenomenon known as the "obesity paradox." This concept shows that overweight people have the lowest all-cause mortality rates while fit people, oddly enough, have mortality rates comparable to those categorized as slightly obese.

Option B+ to prevent maternal transmission of HIV shows rise in women initiating therapy

February 23, 2016 -- The first findings from a study in the Kingdom of Swaziland on a new approach to reduce mother to child transmission of HIV were presented at the annual Conference on Retroviruses and Opportunistic Infections (CROI 2016) in Boston.

Underwater robots can be programmed to make independent decisions

More than 70 percent of the Earth's surface is covered by water, yet scientists know more about space than about what happens in the ocean.

One way scientists are trying to improve their understanding of the marine environment is through the use of autonomous underwater vehicles (AUVs), programmable robotic vehicles that can independently study the ocean and its inhabitants.

But data collected by AUVs takes time to analyze and interpret, and scientists often lose the ability to use this critical information in real-time.

Feinstein Institute researcher presents new definitions for sepsis and septic shock

MANHASSET, NY - Clifford S. Deutschman, MS, MD, vice chair of research in the Department of Pediatrics at Cohen Children's Medical Center and an investigator at The Feinstein Institute for Medical Research , presented new definitions and clinical criteria for sepsis and septic shock at the Society of Critical Care Medicine's (SCCM) 45th Critical Care Congress in Orlando, FL. He was also corresponding author for an article outlining the findings that was published February 23 in The Journal of the American Medical Association (JAMA).

Zolodrenic acid can prevent early bone loss in HIV patients on antiretroviral therapy

A single dose of the drug zoledronic acid was found to inhibit the bone loss that is common in HIV-infected patients and that is increased during the first two years of treatment with antiretroviral therapy (ART). Bone loss also leads to a higher rate of fracture in HIV-infected individuals.

Clinical manual addresses how to approach organ donation after euthanasia

A new practical manual addresses the controversial topic of organ donation after euthanasia, providing guidance to clinicians whose patients have requested euthanasia and the desire to offer their organs to others in need. The manual is published in the American Journal of Transplantation.

A new recipe for biofuel: Genetic diversity can lead to more productive growth

Before farmers settled the Midwestern United States and planted crops, the extensive root systems of prairie grasses--including the tall, strong-stemmed switchgrass species--enriched the soil, creating millions of acres of prime farmland. Today, scientists are exploring how grasses, and switchgrass in particular, can enrich the nation's biofuel supply, which is currently dominated by corn, a crop relatively easy to convert to biofuel but also in demand for food, livestock feed and industrial products.

Food-based proteins discovered as key to child malnutrition in developing countries

Contrary to popular belief among world relief workers, children in developing countries may not be eating enough protein, which could contribute to stunted growth, a Johns Hopkins-directed study suggests.

Internal dissension cited as reason for Cahokia's dissolution

Champaign, IL Dr. Thomas E. Emerson and Dr. Kristin M. Hedman from the Illinois State Archaeological Survey-Prairie Research Institute at the University of Illinois present a new case for Cahokia's demise. The new theory was published in Southern Illinois University Press' volume, Beyond Collapse: Archaeological Perspectives on Resilience, Revitalization, and Transformation in Complex Societies.

New therapeutic pathway may keep cancer cells turned 'off'

Osteosarcoma is a cancer that develops in the bones of children and adolescents. It is one of the most aggressive cancers, with only a 15 per cent, five-year survival rate when diagnosed in an advanced metastatic stage. There are approximately 800 new cases diagnosed each year in the US, and no viable treatments.

A new Tel Aviv University study offers tangible hope of a therapeutic pathway to keep osteosarcoma lesions dormant. It also provides the fundamental basic-science for novel nanomedicines tailored to maintain cancer cells in an asymptomatic state.

New surgical tool keeps orthopedic procedures on target

In the United States alone, hip fracture fixation is performed on 258,000 patients; spinal fusion accounts for 350,000 persons every year. As the population ages, the number of these surgical procedures will continue to grow.